Oklo (OKLO) stock is getting fresh attention from analysts, with Wedbush’s Daniel Ives setting a $110 price target — implying roughly 65% upside over the next 12 months. The stock currently sits around $66.
Oklo Inc., OKLO
Ives ranks in the top 3% of Wall Street analysts and rates OKLO as Outperform. His bullish case centers on Oklo’s “build, own, and operate” model, which he says creates recurring revenue streams and a more efficient path through nuclear regulation.
The catalyst for his latest note was Oklo’s selection by the U.S. Department of Energy for advanced negotiations under the Surplus Plutonium Utilization Program. Four other advanced nuclear companies were also chosen.
The program aims to convert surplus plutonium into fuel for advanced reactors. For Oklo, that means partnering with Newcleo — Oklo leads on plutonium utilization while Newcleo brings fuel expertise and up to $2 billion in potential project capital.
Ives called the DOE selection formal government validation of the Newcleo partnership first announced in October 2025. It also opens a fourth fuel pathway for Oklo, alongside HALEU enrichment, used fuel recycling, and its A3F fabrication program.
That said, Ives was measured in his enthusiasm. He described the DOE announcement as “additive” to Oklo’s fuel strategy rather than a near-term commercial catalyst, noting that definitive agreements and regulatory approvals are still pending.
On May 22, Bank of America analyst Rinny Singh reinstated coverage with a Buy rating and an $80 price target. That implies over 17% upside from current levels.
BofA pointed to Oklo’s vertically integrated model as a potential early-mover advantage in the small modular reactor space. The firm also highlighted the 1.2 GWe binding power agreement signed with Meta in January as evidence of real commercial traction.
Oklo’s broader pipeline stands at more than 14 GWe under non-binding customer letters, making it one of the larger players in the emerging SMR sector by contracted demand.
Oklo’s first Aurora reactor deployment at Idaho National Laboratory is still on track for late 2027 to early 2028. The company is also targeting a July 4, 2026 criticality milestone — its planned first controlled self-sustaining nuclear chain reaction.
Ives said the DOE news doesn’t accelerate that timeline. But he noted that successful conversion of surplus plutonium into bridge fuel could reduce fuel availability risk for those initial deployments, if agreements are finalized.
Wall Street’s consensus sits at a Moderate Buy, with 11 Buys and 7 Holds. The average price target is $90.07, which still points to around 35% upside from current levels.
The AI infrastructure buildout is fueling demand for reliable power at scale, and Oklo’s existing contracts with hyperscalers like Meta show it is already moving to meet that demand.
The post Oklo Stock: BofA and Wedbush Both Rate It a Buy in May 2026 appeared first on CoinCentral.


